{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:43:55Z","timestamp":1777884235266,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008061","name":"Mutua Madrile\u00f1a Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trim.2026.102363","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:20:23Z","timestamp":1771028423000},"page":"102363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of desensitizing therapies for donor-specific antibodies in confirmed humoral allograft rejection in kidney transplantation: Experience of a center for 10\u00a0years"],"prefix":"10.1016","volume":"95","author":[{"given":"Marta","family":"Mart\u00ednez-Alcaraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Botella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Gali\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Alegr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Hita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Rosa","family":"Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helios","family":"Martinez-Banaclocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Muro-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Minguela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Legaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102363_bb0005","series-title":"Revista M\u00e9dica de Panam\u00e1 - ISSN 2412-642X","first-page":"14","article-title":"Proceso de desensibilizaci\u00f3n ANTI-HLA en receptores de donante vivo HLA Clase II incompatible con anticuerpos donante espec\u00edfico","author":"Courville","year":"2021"},{"issue":"5","key":"10.1016\/j.trim.2026.102363_bb0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2016.06.009","article-title":"Plasmapheresis for the treatment of kidney diseases","volume":"90","author":"Clark","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2026.102363_bb0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.trim.2026.102363_bb0020","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ctr.12335","article-title":"Desensitization in kidney transplantation: review and future perspectives","volume":"28","author":"Abu Jawdeh","year":"2014","journal-title":"Clin. Transpl."},{"issue":"4","key":"10.1016\/j.trim.2026.102363_bb0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: a multicenter, prospective, randomized, double-blind clinical trial","volume":"18","author":"Moreso","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"1\u20133","key":"10.1016\/j.trim.2026.102363_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000493521","article-title":"Plasmapheresis therapy in kidney transplant rejection","volume":"47","author":"Xie","year":"2019","journal-title":"Blood Purif."},{"issue":"4","key":"10.1016\/j.trim.2026.102363_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.trim.2026.102363_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ajt.15634","article-title":"Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells","volume":"20","author":"Woodle","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102363_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A randomized trial of Bortezomib in late antibody-mediated kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.trim.2026.102363_bb0050","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/ajt.14222","article-title":"Proteasome inhibitor carfilzomib-based therapy for antibody-mediated rejection of the pulmonary allograft: use and short-term findings","volume":"17","author":"Ensor","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.trim.2026.102363_bb0055","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2026.102363_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-022-00567-1","article-title":"Complement inhibition in kidney transplantation: where are we now?","volume":"37","author":"Vonbrunn","year":"2023","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.trim.2026.102363_bb0065","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/TP.0000000000004822","article-title":"Chronic active antibody-mediated rejection: opportunity to determine the role of interleukin-6 blockade","volume":"108","author":"Berger","year":"2024","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2026.102363_bb0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/TP.0000000000002895","article-title":"Impact of tocilizumab (anti\u2013IL-6R) treatment on immunoglobulins and anti-HLA antibodies in kidney transplant patients with chronic antibody-mediated rejection","volume":"104","author":"Shin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2026.102363_bb0075","series-title":"Monitorizaci\u00f3n inmunol\u00f3gica en trasplantes","author":"Muro","year":"2015"},{"key":"10.1016\/j.trim.2026.102363_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.547849","article-title":"PCR Array technology in biopsy samples identifies up-regulated mTOR pathway genes as potential rejection biomarkers after kidney transplantation","volume":"8","author":"Legaz","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.trim.2026.102363_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11040641","article-title":"Monitoring of B cell in kidney transplantation: development of a novel clusters analysis and role of transitional B cells in transplant outcome","volume":"11","author":"Alfaro","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.trim.2026.102363_bb0090","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell\u2013 and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2026.102363_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001680","article-title":"Risk stratification before living donor kidney transplantation in patients with preformed donor-specific antibodies by different crossmatch methods","volume":"10","author":"Ziemann","year":"2024","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.trim.2026.102363_bb0100","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.3389\/ti.2022.10511","article-title":"European guideline for the Management of Kidney Transplant Patients with HLA antibodies: by the European society for organ transplantation working group","volume":"35","author":"Mamode","year":"2022","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2026.102363_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.839380","article-title":"Tocilizumab and active antibody-mediated rejection in kidney transplantation: a literature review","volume":"13","author":"Cabezas","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2026.102363_bb0110","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of tocilizumab (anti-Interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant Glomerulopathy in HLA-sensitized renal allograft recipients","volume":"17","author":"Choi","year":"2027","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2026.102363_bb0115","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Coll, V.; Llorente, S.; Boix, F.; Alfaro, R.; Gali\u00e1n, J.A.; Mart\u00ednez-Banaclocha, H.; Botella, C.; Moya-Quiles, M.R.; Muro-P\u00e9rez, M.; Minguela, A.; etal. Monitoring of serological, cellular and genomic biomarkers in transplantation, computational prediction models and role of cell-free DNA in transplant outcome. Int. J. Mol. Sci. 2023, 24,3908.","DOI":"10.3390\/ijms24043908"},{"key":"10.1016\/j.trim.2026.102363_bb0120","doi-asserted-by":"crossref","first-page":"1206929","DOI":"10.3389\/fimmu.2023.1206929","article-title":"Molecular immune monitoring in kidney transplant rejection: a state-of-the-art review","volume":"14","author":"Chancharoenthana","year":"2023","journal-title":"Front.Immunol."},{"key":"10.1016\/j.trim.2026.102363_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/TP.0000000000001849","article-title":"Anti-CD20 blocker rituximab in kidney transplantation","volume":"102","author":"Sood","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2026.102363_bb0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.nefro.2021.06.009","article-title":"Tocilizumab en el tratamiento del rechazo humoral cr\u00f3nico activo resistente a terapia est\u00e1ndar","volume":"42","author":"Chamoun","year":"2022","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.trim.2026.102363_bb0135","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.trim.2026.102363_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001695","article-title":"Anti-HLA class II antibodies are the most resistant to desensitization in crossmatch-positive living-donor kidney transplantations: a patient series","volume":"10","author":"de Weerd","year":"2024","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.trim.2026.102363_bb0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.transproceed.2024.01.030","article-title":"Impact of HLA Eplet mismatch on De novo donor specific antibody formation after kidney transplantation","volume":"56","author":"Yanyiam","year":"2024","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2026.102363_bb0150","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1097\/TP.0000000000002682","article-title":"Subclinical inflammation in renal transplantation","volume":"103","author":"Rush","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2026.102363_bb0155","article-title":"Donor HLA-DQ reactive B cells clonally expand under chronic immunosuppression and include atypical CD21 (low) CD27 (\u2212) B cells with high-avidity germline B-cell receptors","author":"Russum","year":"2024","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.trim.2026.102363_bb0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncprheum0424","article-title":"Drug insight: the mechanism of action of rituximab in autoimmune disease\u2014the immune complex decoy hypothesis","volume":"3","author":"Taylor","year":"2007","journal-title":"Nature Clin.Prac.Rheumatol."},{"key":"10.1016\/j.trim.2026.102363_bb0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MOT.0000000000000658","article-title":"Non-invasive biomarkers in monitoring kidney allograft health","volume":"24","author":"O\u2019Callaghan","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.trim.2026.102363_bb0170","doi-asserted-by":"crossref","first-page":"1461480","DOI":"10.3389\/fimmu.2024.1461480","article-title":"Application of graft-derived cell-free DNA for solid organ transplantation","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2026.102363_bb0175","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/life14111491","article-title":"Early monitoring of donor-derived cell-free DNA in kidney allograft recipients followed-up for two years: experience of one center","volume":"14","author":"Botella","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.trim.2026.102363_bb0180","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1600-6143.2005.00988.x","article-title":"Safety and adequacy of renal transplant protocol biopsies","volume":"5","author":"Schwarz","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2026.102363_bb0185","doi-asserted-by":"crossref","unstructured":"Glotz, D., Antoine, C., Julia, P., Pegaz-Fiornet, B., Duboust, A., Boudjeltia, S., Fraoui, R., Combes, M., & Bariety, J. (2004). Intravenous immunoglobulins and transplantation for patients with anti-HLA antibodies. Transpl. Int., 2004,17, 1\u20138.","DOI":"10.1111\/j.1432-2277.2004.tb00376.x"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:17:48Z","timestamp":1777601868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":37,"alternative-id":["S0966327426000213"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102363","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of desensitizing therapies for donor-specific antibodies in confirmed humoral allograft rejection in kidney transplantation: Experience of a center for 10\u00a0years","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102363"}}